Citation Impact
Citing Papers
Enhanced B-1 Cell Development, But Impaired IgG Antibody Responses in Mice Deficient in Secreted IgM
1998
AID−/−μs−/− Mice Are Agammaglobulinemic and Fail to Maintain B220−CD138+ Plasma Cells
2007 StandoutNobel
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
1993 Standout
Influence of Castration, Alone or Combined with Thymectomy, on the Development of Diabetes in the Nonobese Diabetic Mouse*
1991
Interleukin-6 in Biology and Medicine
1993
The rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myeloma
2006
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Selective enhancement of the tumour necrotic activity of TNF α with monoclonal antibody
1992
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Is Type II diabetes mellitus a disease of the innate immune system?
1998
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines.
1996
Inflammation and insulin resistance
2006 Standout
Type 2 diabetes as an inflammatory disease
2011 Standout
Interleukin 6 and its Receptor: Ten Years Later
1998
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’
1991
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Combinatorial infection andin vivorecombination: a strategy for making large phage antibody repertoires
1993 StandoutNobel
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Human Antibody Fragments Specific for Human Blood Group Antigens from a Phage Display Library
1993 StandoutNobel
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Impedance sensing of allergen–antibody interaction on glassy carbon electrode modified by gold electrodeposition
2006
Interleukin‐6 and its receptor in cancer
2007
Autoimmunity and Apoptosis
2001 StandoutNobel
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an Antigen
1994 StandoutNobel
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
1991
Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.
1994
Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
1992 Standout
Phage antibodies against an unstable hapten: Oxygen sensitive reduced flavin
1996 StandoutNobel
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome
2001
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans
2002 Standout
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium
1996 StandoutNobel
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
2003 Standout
Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.
1994 StandoutNobel
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
A primer on cytokines: sources, receptors, effects, and inducers
1997
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Inflammation and Atherosclerosis
2002 Standout
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
1997
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein
2001 StandoutNobel
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia
1996
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Lipopolysaccharide Endotoxins
2002 Standout
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
1996
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Interleukin-1 and interleukin-1 antagonism
1991 Standout
Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis.
1992
Interleukin-8 as a Macrophage-Derived Mediator of Angiogenesis
1992 StandoutScience
Human anti-self antibodies with high specificity from phage display libraries.
1993
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
1994
Works of M Svenson being referenced
Vaccination for birch pollen allergy Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1
2002
Autoantibodies to cytokines - friends or foes?
1990
Influence of interleukin‐6 (IL‐6) autoantibodies on IL‐6 binding to cellular receptors
1995
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist
1997
Anti‐Interleukin‐6 Autoantibodies in Plasma are Associated with an Increased Frequency of Infections and Increased Mortality of Patients with Alcoholic Cirrhosis
1996
Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group.
1989
Interleukin-6 (IL-6) autoantibodies and blood IL-6 measurements [letter]
1995
Interleukin-6 autoantibodies: possible biological and clinical significance.
1995